Business ❯ Pharmaceuticals ❯ Acquisitions

Biotechnology

Weight Loss Novo Nordisk RNA Therapeutics Cidara Therapeutics Cancer Treatment

Johnson & Johnson to Buy Halda Therapeutics for $3.05 Billion to Bolster Oncology Pipeline

The deal would bring Halda’s RIPTAC technology plus prostate cancer pill HLD-0915 under J&J pending antitrust clearance.

Merck to Buy Cidara for $9.2 Billion to Secure Long-Acting Flu Drug

Pfizer to Buy Metsera in Up to $7.3 Billion Obesity Bet